- Home
- UCL vs OMIC Comparison
UCL vs OMIC Comparison
Compare UCL & OMIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCL
- OMIC
- Stock Information
- Founded
- UCL 2014
- OMIC 2016
- Country
- UCL Hong Kong
- OMIC United States
- Employees
- UCL N/A
- OMIC N/A
- Industry
- UCL Telecommunications Equipment
- OMIC Medical/Dental Instruments
- Sector
- UCL Consumer Discretionary
- OMIC Health Care
- Exchange
- UCL Nasdaq
- OMIC Nasdaq
- Market Cap
- UCL 48.7M
- OMIC 50.4M
- IPO Year
- UCL 2020
- OMIC 2021
- Fundamental
- Price
- UCL $1.32
- OMIC $19.91
- Analyst Decision
- UCL
- OMIC Hold
- Analyst Count
- UCL 0
- OMIC 2
- Target Price
- UCL N/A
- OMIC $10.75
- AVG Volume (30 Days)
- UCL 176.7K
- OMIC 7.0K
- Earning Date
- UCL 03-13-2025
- OMIC 03-17-2025
- Dividend Yield
- UCL N/A
- OMIC N/A
- EPS Growth
- UCL 169.91
- OMIC N/A
- EPS
- UCL 0.11
- OMIC N/A
- Revenue
- UCL $87,405,000.00
- OMIC $2,667,000.00
- Revenue This Year
- UCL $7.02
- OMIC $0.82
- Revenue Next Year
- UCL $15.25
- OMIC $252.64
- P/E Ratio
- UCL $11.72
- OMIC N/A
- Revenue Growth
- UCL 4.73
- OMIC 2.77
- 52 Week Low
- UCL $0.97
- OMIC $5.34
- 52 Week High
- UCL $3.30
- OMIC $23.41
- Technical
- Relative Strength Index (RSI)
- UCL 43.55
- OMIC 49.98
- Support Level
- UCL $1.27
- OMIC $19.73
- Resistance Level
- UCL $1.42
- OMIC $19.90
- Average True Range (ATR)
- UCL 0.13
- OMIC 0.12
- MACD
- UCL -0.01
- OMIC 0.02
- Stochastic Oscillator
- UCL 9.77
- OMIC 56.52
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc provides mobile data connectivity and portable WiFi services. The business operates under uCloudlink 1.0, which focuses on cross-border travelers that need mobile data connectivity services across different countries. Under uCloudlink 2.0, provides mobile data connectivity services to local users across different MNOs in a single country. It generates revenue from the provision of data connectivity services, and the sales of terminals and sales of data related products.
About OMIC Singular Genomics Systems Inc.
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.